BAX and cancer: Interestingly, baicalin offers great potential in the field of cancer therapeutics also by triggering apoptosis, suppressing miRs, influencing the expression of proteins regulating cell death, enhancing the functions of Bax and p53, and increasing the levels of cyclin-dependent kinase inhibitors when delivered embedded in lipid nanoparticles at the concentration of 13 ± 5 μg/ml [189].